Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thiorphan reprograms neurons to promote functional recovery after spinal cord injury.

Nature·2025
Same author

Dosing parameters for grafting human neural stem cells into sites of spinal cord injury.

Experimental neurology·2025
Same author

In Vitro Accuracy of Digital Versus Conventional Workflows for Complete-Arch Implant- Supported Frameworks-A Scoping Review.

The International journal of prosthodontics·2024
Same author

Cognition and freezing of gait in Parkinson's disease: A systematic review and meta-analysis.

Neuroscience and biobehavioral reviews·2023
Same author

A Southeast Asian collaborative Delphi consensus on surveying risk factors for head and neck cancer screening and prevention.

Global surgery (London)·2022
Same author

Non-invasive assessment of fecal glucocorticoid, progesterone, and androgen metabolites and microbiome in free-ranging southern white rhinoceros (Ceratotherium simum simum) in South Africa.

General and comparative endocrinology·2022
Same journal

Opportunities and challenges for the application of single-cell RNA sequencing and spatial transcriptomics in ischemic stroke.

Experimental neurology·2026
Same journal

Behavioral and functional characterization of early-stage Parkinson's disease models reveals attentional deficits and circuit-level connectivity alterations.

Experimental neurology·2026
Same journal

Neuropathological and functional impact of astrocyte-derived extracellular vesicles in an aged model of Alzheimer's disease.

Experimental neurology·2026
Same journal

PI3K/Akt pathway in ischemic stroke: A central regulator of neuronal survival and repair.

Experimental neurology·2026
Same journal

Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis.

Experimental neurology·2026
Same journal

Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies.

Experimental neurology·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2025

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
12:06

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells

Published on: January 28, 2015

12.5K

An improved method for generating human spinal cord neural stem cells.

Y Li1, H Kumamaru2, T J Vokes1

  • 1Department of Neurosciences, University of California - San Diego, La Jolla, CA, United States of America.

Experimental Neurology
|April 15, 2024
PubMed
Summary
This summary is machine-generated.

Optimized neural stem cell lines improve spinal cord injury (SCI) treatment. These cells, differentiated for spinal cord fate, enhance axonal regeneration and functional recovery in preclinical models, paving the way for safer human trials.

Keywords:
Neural stem cellsSpinal cord

More Related Videos

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue
07:29

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Published on: May 25, 2011

15.5K
Isolation of Neural Stem/Progenitor Cells from the Periventricular Region of the Adult Rat and Human Spinal Cord
08:26

Isolation of Neural Stem/Progenitor Cells from the Periventricular Region of the Adult Rat and Human Spinal Cord

Published on: May 14, 2015

12.3K

Related Experiment Videos

Last Updated: Jun 28, 2025

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
12:06

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells

Published on: January 28, 2015

12.5K
Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue
07:29

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Published on: May 25, 2011

15.5K
Isolation of Neural Stem/Progenitor Cells from the Periventricular Region of the Adult Rat and Human Spinal Cord
08:26

Isolation of Neural Stem/Progenitor Cells from the Periventricular Region of the Adult Rat and Human Spinal Cord

Published on: May 14, 2015

12.3K

Area of Science:

  • Regenerative Medicine
  • Neuroscience
  • Stem Cell Biology

Background:

  • Neural stem cells (NSCs) show promise for spinal cord injury (SCI) treatment.
  • Previous research indicated that directing NSCs to a spinal cord fate optimizes axonal regeneration and functional recovery.
  • Established methods for deriving human spinal cord NSCs from embryonic stem cells (ESCs) support high-passage culturing for clinical applications.

Purpose of the Study:

  • To further optimize the derivation and culture of human spinal cord NSC lines.
  • To enhance karyotypic stability while maintaining in vivo efficacy.
  • To improve the safety and feasibility of human clinical translation for SCI.

Main Methods:

  • Development of optimized protocols for deriving and culturing human spinal cord NSC lines from ESCs.
  • Assessment of karyotypic stability over serial high-passage culturing.
  • Evaluation of the anatomical efficacy of these optimized NSC lines in preclinical SCI models.

Main Results:

  • Achieved improved karyotypic stability in human spinal cord NSC lines during extended in vitro culturing.
  • Maintained the anatomical efficacy of these optimized cell lines in vivo, demonstrating their ability to support axonal regeneration and form neural relays.
  • Successfully sustained cell cultures over serial high passage numbers, ensuring a robust cell source.

Conclusions:

  • Optimized human spinal cord NSC lines offer enhanced karyotypic stability and sustained efficacy.
  • These improved cell lines represent a more robust and safer cell source for clinical trials in spinal cord injury.
  • Further development enhances the prospects for successful translation of NSC-based therapies for SCI patients.